Cenra Inc. (TPE:3716)
36.95
-0.10 (-0.27%)
At close: May 13, 2025, 1:30 PM CST
Cenra Revenue
In the year 2024, Cenra had annual revenue of 8.92B TWD with 4.01% growth. Cenra had revenue of 2.26B in the quarter ending December 31, 2024, a decrease of -0.73%.
Revenue
8.92B
Revenue Growth
+4.01%
P/S Ratio
0.62
Revenue / Employee
16.46M
Employees
542
Market Cap
5.49B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 8.92B | 344.17M | 4.01% |
Dec 31, 2023 | 8.57B | 118.21M | 1.40% |
Dec 31, 2022 | 8.46B | 507.51M | 6.38% |
Dec 31, 2021 | 7.95B | -232.06M | -2.84% |
Dec 31, 2020 | 8.18B | 211.36M | 2.65% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 11.34B |
Caliway Biopharmaceuticals | 40.47M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 18.58B |
Polaris Group | 107.00M |
Oneness Biotech | 117.93M |
Pegavision | 6.69B |
Lumosa Therapeutics | 43.59M |